Nevro (NVRO) Competitors $5.72 0.00 (0.00%) Closing price 02/12/2025 03:59 PM EasternExtended Trading$5.72 0.00 (0.00%) As of 02/12/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NVRO vs. SIBN, TMCI, KIDS, DCTH, SMLR, CLPT, TCMD, NNOX, NPCE, and ZIMVShould you be buying Nevro stock or one of its competitors? The main competitors of Nevro include SI-BONE (SIBN), Treace Medical Concepts (TMCI), OrthoPediatrics (KIDS), Delcath Systems (DCTH), Semler Scientific (SMLR), ClearPoint Neuro (CLPT), Tactile Systems Technology (TCMD), Nano-X Imaging (NNOX), NeuroPace (NPCE), and ZimVie (ZIMV). These companies are all part of the "medical equipment" industry. Nevro vs. SI-BONE Treace Medical Concepts OrthoPediatrics Delcath Systems Semler Scientific ClearPoint Neuro Tactile Systems Technology Nano-X Imaging NeuroPace ZimVie SI-BONE (NASDAQ:SIBN) and Nevro (NYSE:NVRO) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, community ranking, media sentiment, profitability, risk, institutional ownership and analyst recommendations. Does the MarketBeat Community favor SIBN or NVRO? Nevro received 335 more outperform votes than SI-BONE when rated by MarketBeat users. However, 68.42% of users gave SI-BONE an outperform vote while only 63.00% of users gave Nevro an outperform vote. CompanyUnderperformOutperformSI-BONEOutperform Votes16968.42% Underperform Votes7831.58% NevroOutperform Votes50463.00% Underperform Votes29637.00% Do analysts prefer SIBN or NVRO? SI-BONE currently has a consensus target price of $23.00, indicating a potential upside of 41.80%. Nevro has a consensus target price of $6.43, indicating a potential upside of 12.33%. Given SI-BONE's stronger consensus rating and higher probable upside, equities research analysts plainly believe SI-BONE is more favorable than Nevro.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SI-BONE 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Nevro 2 Sell rating(s) 11 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.93 Which has stronger valuation & earnings, SIBN or NVRO? SI-BONE has higher earnings, but lower revenue than Nevro. SI-BONE is trading at a lower price-to-earnings ratio than Nevro, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSI-BONE$138.89M4.90-$43.34M-$0.92-17.63Nevro$425.17M0.50-$92.21M-$1.89-3.03 Which has more volatility & risk, SIBN or NVRO? SI-BONE has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500. Comparatively, Nevro has a beta of 0.91, indicating that its stock price is 9% less volatile than the S&P 500. Does the media prefer SIBN or NVRO? In the previous week, Nevro had 22 more articles in the media than SI-BONE. MarketBeat recorded 25 mentions for Nevro and 3 mentions for SI-BONE. Nevro's average media sentiment score of 0.51 beat SI-BONE's score of 0.14 indicating that Nevro is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SI-BONE 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nevro 4 Very Positive mention(s) 3 Positive mention(s) 14 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Is SIBN or NVRO more profitable? Nevro has a net margin of -16.54% compared to SI-BONE's net margin of -23.82%. SI-BONE's return on equity of -22.51% beat Nevro's return on equity.Company Net Margins Return on Equity Return on Assets SI-BONE-23.82% -22.51% -16.53% Nevro -16.54%-23.52%-10.83% Do insiders & institutionals have more ownership in SIBN or NVRO? 98.1% of SI-BONE shares are held by institutional investors. Comparatively, 95.5% of Nevro shares are held by institutional investors. 3.9% of SI-BONE shares are held by insiders. Comparatively, 3.2% of Nevro shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummarySI-BONE beats Nevro on 11 of the 18 factors compared between the two stocks. Get Nevro News Delivered to You Automatically Sign up to receive the latest news and ratings for NVRO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NVRO vs. The Competition Export to ExcelMetricNevroSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$214.33M$4.67B$5.66B$20.22BDividend YieldN/A51.43%5.31%3.67%P/E Ratio-3.0325.0090.3644.90Price / Sales0.5055.761,035.7316.23Price / CashN/A50.3946.0920.34Price / Book0.716.925.135.73Net Income-$92.21M$87.36M$113.24M$1.00B7 Day Performance13.83%-2.60%-0.99%-1.10%1 Month Performance74.39%1.20%4.19%3.51%1 Year Performance-67.13%19.03%21.68%15.05% Nevro Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NVRONevro2.0129 of 5 stars$5.72flat$6.43+12.3%-67.1%$214.33M$425.17M-3.031,215Upcoming EarningsAnalyst UpgradeSIBNSI-BONE4.3088 of 5 stars$17.02+1.6%$23.00+35.1%-24.8%$713.79M$157.04M-18.50350Gap DownTMCITreace Medical Concepts0.8642 of 5 stars$9.69-3.6%$8.98-7.3%-38.1%$603.69M$187.12M-9.79250Gap DownKIDSOrthoPediatrics4.5849 of 5 stars$24.05+0.2%$39.00+62.2%-14.7%$582.49M$148.73M-19.55200Short Interest ↓DCTHDelcath Systems3.1224 of 5 stars$15.45-1.0%$22.25+44.0%+229.5%$493.94M$2.07M-11.4460Short Interest ↑Positive NewsGap DownSMLRSemler Scientific2.9301 of 5 stars$50.46-2.9%$71.00+40.7%-0.9%$467.61M$58.94M24.61120Short Interest ↑Positive NewsGap DownCLPTClearPoint Neuro1.5884 of 5 stars$16.95-2.9%$19.67+16.0%+140.7%$467.48M$23.95M-24.57110Short Interest ↓News CoverageGap DownTCMDTactile Systems Technology3.6335 of 5 stars$17.34-1.0%$23.00+32.6%+7.8%$416.16M$274.42M26.68980Upcoming EarningsNNOXNano-X Imaging2.6882 of 5 stars$7.08-2.7%$17.50+147.2%+5.3%$409.08M$9.90M-8.33190NPCENeuroPace3.3389 of 5 stars$13.61-1.1%$14.80+8.7%-24.5%$406.26M$65.42M-13.61170Short Interest ↓ZIMVZimVie2.5202 of 5 stars$13.74-0.7%$19.50+41.9%-33.9%$379.22M$457.43M-1.052,600 Related Companies and Tools Related Companies SI-BONE Competitors Treace Medical Concepts Competitors OrthoPediatrics Competitors Delcath Systems Competitors Semler Scientific Competitors ClearPoint Neuro Competitors Tactile Systems Technology Competitors Nano-X Imaging Competitors NeuroPace Competitors ZimVie Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:NVRO) was last updated on 2/13/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredHe called the top and bottom of Bitcoin nearly to the day … Here’s what he says is next.With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nevro Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nevro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.